RESUMO
PURPOSE: This study aims to evaluate the association between composition of tumor-infiltrating lymphocytes (TIL) and expression of p16 in acral lentiginous melanoma (ALM), and their impact on prognosis. MATERIALS AND METHODS: A cohort of 148 surgical pathology specimens of ALM was studied. TIL were evaluated by immunohistochemical detection of CD3 and CD8, along with CD20, CD4, CD68, and CD163 in a subset of 43 cases. p16 protein expression was also investigated in all the cases. RESULTS: The median age was 66 years, median Breslow thickness was 6.0 mm, grade III TIL was found in 28.4% and lymph nodes were involved in 54.2%. Breslow thickness (p < 0.001), stage I-II (p < 0.001), negative lymph nodes (p < 0.001) and < 10% p16 (p = 0.01) were associated with longer survival. Grade III of TIL was associated with thinner Breslow thickness (p = 0.008) and lower mitosis (p = 0.047). A higher density of CD3 TIL was associated with male gender (p = 0.008), thinner Breslow thickness (p = 0.047), negative lymph node (p = 0.031), early stage (p = 0.046), and p16 nuclear expression of > 10% (p = 0.045). Higher CD8 TIL was associated with > p16 (p = 0.03). Survival analysis found that longer survival had a trend to be associated with high TIL (p = 0.090). Levels of CD3+ and CD8+ cells were correlated with those of CD4+, CD20+, CD68+ and CD163+ immune cells. CONCLUSIONS: Higher levels of TIL tend to be associated with better overall survival in ALM. Loss of expression of p16 is associated with lower levels of CD3+ and CD8+ TIL, indicating a probable relationship between p16 and TIL immune response in ALM .
Assuntos
Biomarcadores Tumorais/análise , Inibidor p16 de Quinase Dependente de Ciclina/metabolismo , Lentigo/patologia , Linfócitos do Interstício Tumoral/imunologia , Melanoma/patologia , Neoplasias Cutâneas/patologia , Adulto , Idoso , Idoso de 80 Anos ou mais , Estudos de Coortes , Feminino , Seguimentos , Humanos , Lentigo/imunologia , Lentigo/metabolismo , Masculino , Melanoma/imunologia , Melanoma/metabolismo , Pessoa de Meia-Idade , Prognóstico , Neoplasias Cutâneas/imunologia , Neoplasias Cutâneas/metabolismo , Taxa de Sobrevida , Melanoma Maligno CutâneoAssuntos
Lentigo/diagnóstico , Melanócitos/patologia , Nevo de Células Epitelioides e Fusiformes/diagnóstico , Vitiligo/diagnóstico , Criança , Feminino , Humanos , Lentigo/complicações , Lentigo/imunologia , Melanócitos/imunologia , Nevo de Células Epitelioides e Fusiformes/complicações , Nevo de Células Epitelioides e Fusiformes/imunologia , Vitiligo/complicações , Vitiligo/imunologiaAssuntos
Antígenos HLA-G/metabolismo , Interleucina-10/metabolismo , Lentigo/patologia , Melanoma/patologia , Neoplasias Cutâneas/patologia , Adulto , Idoso , Biópsia , Progressão da Doença , Feminino , Antígenos HLA-G/imunologia , Humanos , Interleucina-10/imunologia , Lentigo/imunologia , Masculino , Melanoma/imunologia , Pessoa de Meia-Idade , Prognóstico , Pele/imunologia , Pele/patologia , Neoplasias Cutâneas/imunologiaRESUMO
We investigated 115 individuals in Tokyo from two groups of persons with conspicuous nevi on the head, neck, and arms, etc. (nevus-positive group) and persons who do not exhibit such nevi (nevi-negative group) interviewing them to determine whether they suffered from allergic rhinitis/conjunctivitis (pollinosis) and examining them for the presence and extent of nevi. There was a distinct correlation: only 5 persons among 85 individuals of the nevus-positive group suffered from pollinosis, and all 30 people in the nevus-negative group had pollinosis. Thus, individuals exhibiting conspicuous nevi are resistant to pollinosis, but those who do not show increased susceptibility to pollinosis.
Assuntos
Conjuntivite Alérgica/imunologia , Lentigo/imunologia , Rinite Alérgica Sazonal/imunologia , Adolescente , Adulto , Feminino , Humanos , Japão , Masculino , Pessoa de Meia-Idade , Pólen/imunologiaAssuntos
Anticorpos Antinucleares/biossíntese , Etretinato/administração & dosagem , Lentigo/induzido quimicamente , Terapia PUVA , Psoríase/tratamento farmacológico , Administração Oral , Adolescente , Adulto , Idoso , Etretinato/uso terapêutico , Feminino , Humanos , Lentigo/imunologia , Masculino , Pessoa de Meia-Idade , Terapia PUVA/efeitos adversosRESUMO
Three patients with biopsy-proven lentigo maligna were treated with topical 5-fluorouracil. Treatment consisted of twice daily application of 5% 5-fluorouracil cream for 13, 6, and 9 weeks, respectively. Two patients demonstrated presence of invasive melanoma; in one the melanoma was evident before chemotherapy, and in the other the lesion became evident after chemotherapy. In both the lentigo was treated topically and the melanoma excised locally. Posttreatment followup times through April 1, 1974 have been 42, 24, and 22 months, respectively. There has been no evidence of metastases in any patient. Topical chemotherapy with 5-fluorouracil cream appears to offer an encouraging alternative method of therapy for lentigo maligna of the face.